Chidamide, a subtype-selective histone deacetylase inhibitor, enhances Bortezomib effects in multiple myeloma therapyYanjuan He, Fangping Chen, Jiliang Xia et al.|Journal of Cancer|2021Cited by 10
Additional file 17 of Alterations of gut microbiome accelerate multiple myeloma progression by increasing the relative abundances of nitrogen-recycling bacteriaXingxing Jian, Wen Zhou, Yinghong Zhu et al.|Figshare|2020Cited by 0
Additional file 8 of Alterations of gut microbiome accelerate multiple myeloma progression by increasing the relative abundances of nitrogen-recycling bacteriaXingxing Jian, Wen Zhou, Yinghong Zhu et al.|Figshare|2020Cited by 0